# CNTA (Centessa Pharmaceuticals PLC) - SEC EDGAR Financial Statements

> Centessa Pharmaceuticals PLC reported $0 in revenue and a net loss of $250.6M for the trailing twelve months ended March 31, 2026 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/CNTA
- Markdown: https://convexityos.com/fundamentals/CNTA.md
- SEC CIK: 0001847903
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001847903&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | -100.0% YoY |
| Operating Income | TTM | -$256.7M | Operating profit |
| Net Income | TTM | -$250.6M | GAAP bottom line |
| Diluted EPS | TTM | -$1.63 | Split-adjusted |
| Free Cash Flow | TTM | -$194.2M | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $276.6M | Total debt: $118.6M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $15.00M | $0 | $6.85M | $0 | -- | -- | -- |
| Research & Development | $172.2M | $150.2M | $124.4M | $155.1M | $95.66M | $9.30M | $4.26M |
| **Operating Income** | -$207.7M | -$201.1M | -$171.3M | -$212.3M | -$374.1M | -$10.44M | -$5.05M |
| **EBITDA** | -$206.8M | -$200.1M | -$170.5M | -$212.1M | -$374.1M | -$10.44M | -$5.05M |
| Interest Income | $20.53M | $14.02M | $10.48M | -- | -- | -- | -- |
| Interest Expense | $11.46M | $10.09M | $9.91M | $7.28M | -- | -- | -- |
| Income Before Tax | -$195.7M | -$232.9M | -$176.1M | -$217.0M | -$381.0M | -$10.66M | -$5.06M |
| Income Tax Expense | $1.82M | $2.84M | -$25.06M | -$747K | $114K | $0 | $0 |
| **Net Income** | -$197.5M | -$235.8M | -$151.1M | -$216.2M | -$381.1M | -$10.66M | -$5.06M |
| Basic EPS | -$1.46 | -$2.06 | -$1.57 | -$2.31 | -$5.07 | -- | -- |
| **Diluted EPS** | -$1.46 | -$2.06 | -$1.57 | -$2.31 | -$5.07 | -- | -- |
| Basic Shares Outstanding | 135.7M | 114.5M | 96.2M | 93.4M | 75.2M | -- | -- |
| Diluted Shares Outstanding | 135.7M | 114.5M | 96.2M | 93.4M | 75.2M | -- | -- |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $15.00M | $0 | $0 | $0 |
| Research & Development | $59.89M | $54.48M | $41.56M | $42.74M | $33.44M | $60.87M | $33.90M | $32.81M |
| **Operating Income** | -$79.77M | -$68.47M | -$53.79M | -$54.65M | -$30.78M | -$74.58M | -$46.41M | -$43.98M |
| **EBITDA** | -$79.53M | -$68.23M | -$53.55M | -$54.43M | -$30.56M | -$74.35M | -$46.17M | -$43.74M |
| Interest Income | $5.14M | $4.49M | $3.77M | $4.38M | $7.89M | $4.84M | $3.34M | $3.24M |
| Interest Expense | $2.73M | $2.81M | $2.89M | $2.88M | $2.88M | $2.48M | $2.56M | $2.52M |
| Income Before Tax | -$78.39M | -$66.69M | -$54.73M | -$49.56M | -$24.74M | -$110.3M | -$41.96M | -$43.11M |
| Income Tax Expense | $850K | -$522K | $166K | $778K | $1.40M | $1.05M | $608K | $705K |
| **Net Income** | -$79.24M | -$66.16M | -$54.89M | -$50.34M | -$26.14M | -$111.3M | -$42.57M | -$43.82M |
| Basic EPS | -$0.52 | -- | -$0.41 | -$0.38 | -$0.20 | -- | -$0.37 | -$0.40 |
| **Diluted EPS** | -$0.52 | -- | -$0.41 | -$0.38 | -$0.20 | -- | -$0.37 | -$0.40 |
| Basic Shares Outstanding | 153.5M | -- | 134.2M | 133.7M | 133.0M | -- | 116.3M | 109.5M |
| Diluted Shares Outstanding | 153.5M | -- | 134.2M | 133.7M | 133.0M | -- | 116.3M | 109.5M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $61.30M | $383.2M | $128.0M | $393.6M | $595.1M | $7.23M |
| Short-Term Investments | $233.3M | $98.96M | $128.5M | $0 | -- | -- |
| **Cash & Short-Term Investments** | $294.6M | $482.2M | $256.5M | $393.6M | $595.1M | $7.23M |
| Other Current Assets | $1.83M | $1.50M | $1.62M | $3.27M | $993K | $6.0K |
| **Total Current Assets** | $367.9M | $536.4M | $315.1M | $437.7M | $628.8M | $11.16M |
| Property, Plant & Equipment, Net | $807K | $744K | $1.04M | $1.17M | $162K | $0 |
| Other Non-Current Assets | $1.44M | $2.05M | $2.55M | $1.88M | $699K | $552K |
| **Total Non-Current Assets** | $319.6M | $40.39M | $45.15M | $6.56M | $861K | $552K |
| **Total Assets** | $687.5M | $576.8M | $360.2M | $444.3M | $629.6M | $11.72M |
| Accounts Payable | $7.58M | $7.14M | $11.81M | $13.84M | $8.06M | $1.03M |
| Short-Term Debt | -- | -- | -- | -- | -- | $5.63M |
| **Total Current Liabilities** | $42.94M | $58.00M | $39.38M | $38.34M | $24.64M | $8.62M |
| Long-Term Debt | $110.1M | $108.9M | $75.70M | $69.80M | $75.70M | $0 |
| Other Non-Current Liabilities | $29K | $29K | $29K | $0 | $43K | $0 |
| **Total Non-Current Liabilities** | $117.7M | $117.3M | $84.62M | $69.80M | $113.4M | $0 |
| **Total Liabilities** | $160.6M | $175.3M | $124.0M | $108.1M | $138.1M | $8.62M |
| **Total Debt (incl. Leases)** | $118.4M | $117.8M | $85.09M | $69.80M | $75.70M | $5.63M |
| Common Stock | $405K | $359K | $273K | $265K | $252K | -- |
| Retained Earnings | -$1.19B | -$988.7M | -$752.9M | -$601.9M | -$385.7M | -- |
| Accumulated Other Comp. Income | $2.71M | $4.21M | $1.49M | -$1.50M | $688K | -- |
| **Total Stockholders' Equity** | $526.9M | $401.5M | $236.2M | $336.2M | $491.6M | -- |
| Total Equity | $526.9M | $401.5M | $236.2M | $336.2M | $491.6M | -- |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $62.43M | $61.30M | $50.81M | $44.24M | $105.2M | $383.2M | $395.0M | $127.4M |
| Short-Term Investments | $214.2M | $233.3M | $195.4M | $206.5M | $179.3M | $98.96M | $123.4M | $167.5M |
| **Cash & Short-Term Investments** | $276.6M | $294.6M | $246.2M | $250.7M | $284.5M | $482.2M | $518.4M | $294.8M |
| Other Current Assets | $2.12M | $1.83M | $2.76M | $1.62M | $1.61M | $1.50M | $2.67M | $1.95M |
| **Total Current Assets** | $348.7M | $367.9M | $307.7M | $300.4M | $347.7M | $536.4M | $568.4M | $355.5M |
| Property, Plant & Equipment, Net | $722K | $807K | $894K | $733K | $681K | $744K | $821K | $903K |
| Other Non-Current Assets | $1.28M | $1.44M | $1.59M | $1.72M | $1.88M | $2.05M | $2.23M | $2.38M |
| **Total Non-Current Assets** | $293.1M | $319.6M | $140.6M | $191.8M | $180.1M | $40.39M | $41.35M | $43.34M |
| **Total Assets** | $641.8M | $687.5M | $448.3M | $492.1M | $527.8M | $576.8M | $609.7M | $398.8M |
| Accounts Payable | $10.66M | $7.58M | $8.68M | $5.69M | $5.13M | $7.14M | $7.44M | $5.32M |
| **Total Current Liabilities** | $36.57M | $42.94M | $29.12M | $29.69M | $24.20M | $58.00M | $26.41M | $26.75M |
| Long-Term Debt | $110.4M | $110.1M | $109.8M | $109.5M | $109.3M | $108.9M | $75.70M | $76.50M |
| Other Non-Current Liabilities | $29K | $29K | $29K | $29K | $29K | $29K | $29K | $29K |
| **Total Non-Current Liabilities** | $117.8M | $117.7M | $117.6M | $117.5M | $117.4M | $117.3M | $84.17M | $85.12M |
| **Total Liabilities** | $154.4M | $160.6M | $146.7M | $147.2M | $141.6M | $175.3M | $110.6M | $111.9M |
| **Total Debt (incl. Leases)** | $118.6M | $118.4M | $118.3M | $118.1M | $118.0M | $117.8M | $84.72M | $85.65M |
| Common Stock | $419K | $405K | $364K | $363K | $362K | $359K | $357K | $309K |
| Retained Earnings | -$1.27B | -$1.19B | -$1.12B | -$1.07B | -$1.01B | -$988.7M | -$877.4M | -$834.8M |
| Accumulated Other Comp. Income | $1.41M | $2.71M | $2.60M | $1.59M | $2.08M | $4.21M | $2.10M | $1.59M |
| **Total Stockholders' Equity** | $487.3M | $526.9M | $301.6M | $344.9M | $386.2M | $401.5M | $499.1M | $287.0M |
| Total Equity | $487.3M | $526.9M | $301.6M | $344.9M | $386.2M | $401.5M | $499.1M | $287.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$197.5M | -$235.8M | -$151.1M | -$216.2M | -$381.1M | -$10.66M | -$5.06M |
| Depreciation & Amortization | $921K | $942K | $810K | $131K | $34K | $0 | $6.0K |
| Stock-Based Compensation | $30.96M | $33.55M | $29.39M | $24.96M | $14.85M | $336K | $236K |
| Change in Payables | $50K | -$4.58M | -$2.72M | $6.35M | $4.16M | -$49K | $855K |
| **Operating Cash Flow** | -$193.8M | -$142.1M | -$160.3M | -$200.5M | -$135.1M | -$10.63M | -$5.83M |
| Capital Expenditure | -$371K | -$34K | -$169K | -$1.14M | -$186K | $0 | $0 |
| **Free Cash Flow** | -$194.2M | -$142.1M | -$160.5M | -$201.7M | -$135.3M | -$10.63M | -$5.83M |
| Purchases of Investments | -$739.8M | -$140.5M | -$264.9M | $0 | -- | -- | -- |
| **Investing Cash Flow** | -$418.5M | $31.27M | -$127.0M | -$931K | $63.26M | $0 | $0 |
| Common Stock Issued | -- | -- | $20.81M | $0 | -- | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -$12K | $0 | $0 |
| **Financing Cash Flow** | $291.5M | $364.8M | $21.12M | $457K | $660.1M | $1.36M | $9.01M |
| **Net Change in Cash** | -$321.3M | $255.2M | -$265.6M | -$201.4M | $590.1M | -$9.34M | $3.70M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$79.24M | -$66.16M | -$54.89M | -$50.34M | -$26.14M | -$111.3M | -$42.57M | -$43.82M |
| Depreciation & Amortization | $239K | $241K | $237K | $226K | $217K | $230K | $236K | $236K |
| Stock-Based Compensation | $10.56M | $7.94M | $7.19M | $7.95M | $7.88M | $8.33M | $8.45M | $8.61M |
| Change in Payables | $3.26M | -$1.31M | $3.28M | $177K | -$2.10M | $143K | $1.71M | -$2.18M |
| **Operating Cash Flow** | -$72.22M | -$55.81M | -$58.31M | -$22.45M | -$57.25M | -$42.80M | -$21.39M | -$40.58M |
| Capital Expenditure | -- | -- | -- | -- | -- | $0 | -$34K | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -$42.80M | -$21.42M | -$40.58M |
| Purchases of Investments | -$75.54M | -$313.7M | -$45.51M | -$83.06M | -$297.5M | $0 | $0 | -$120.5M |
| **Investing Cash Flow** | $42.71M | -$218.1M | $61.95M | -$39.95M | -$222.4M | $25.00M | $44.96M | -$55.46M |
| Common Stock Issued | $0 | -- | -- | -- | $6.11M | -- | -- | -- |
| **Financing Cash Flow** | $30.47M | $283.4M | $3.44M | $1.60M | $3.09M | $2.96M | $246.0M | $105.3M |
| **Net Change in Cash** | $1.13M | $11.14M | $6.57M | -$60.91M | -$278.1M | -$11.80M | $267.7M | $9.15M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1384.6% | -- | -2499.4% | -- | -- | -- | -- |
| **Net Profit Margin** | -1316.9% | -- | -2204.7% | -- | -- | -- | -- |
| Return on Equity (ROE) | -37.5% | -58.7% | -64.0% | -64.3% | -77.5% | -- | -- |
| Return on Assets (ROA) | -28.7% | -40.9% | -41.9% | -48.7% | -60.5% | -91.0% | -- |
| Current Ratio | 8.57x | 9.25x | 8.00x | 11.42x | 25.52x | 1.30x | -- |
| Quick Ratio | 6.86x | 8.31x | 6.51x | 10.27x | 24.15x | 0.84x | -- |
| Debt to Equity | 0.22x | 0.29x | 0.36x | 0.21x | 0.15x | -- | -- |
| **Revenue Growth (YoY)** | -- | -100.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -1384.6% | -1425.3% | -1376.1% | -1304.9% | -- | -- | -- |
| **Net Profit Margin** | -- | -1316.9% | -1618.0% | -1535.8% | -1492.3% | -- | -- | -- |
| Return on Equity (ROE) | -51.4% | -37.5% | -80.5% | -66.8% | -58.0% | -58.7% | -32.3% | -54.8% |
| Return on Assets (ROA) | -39.1% | -28.7% | -54.1% | -46.8% | -42.4% | -40.9% | -26.4% | -39.5% |
| Current Ratio | 9.53x | 8.57x | 10.57x | 10.12x | 14.37x | 9.25x | 21.52x | 13.29x |
| Quick Ratio | 7.56x | 6.86x | 8.45x | 8.44x | 11.76x | 8.31x | 19.63x | 11.02x |
| Debt to Equity | 0.24x | 0.22x | 0.39x | 0.34x | 0.31x | 0.29x | 0.17x | 0.30x |
| **Revenue Growth (YoY)** | -100.0% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
